Literature DB >> 12425585

Evidence-based position statement on the management of irritable bowel syndrome in North America.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12425585     DOI: 10.1016/s0002-9270(02)05656-3

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  24 in total

Review 1.  Irritable bowel syndrome and functional dyspepsia: different diseases or a single disorder with different manifestations?

Authors:  Laura Noddin; Michael Callahan; Brian E Lacy
Journal:  MedGenMed       Date:  2005-08-29

2.  The incidence of abdominal and pelvic surgery among patients with irritable bowel syndrome.

Authors:  J Alexander Cole; Jason M Yeaw; Jennifer A Cutone; Braden Kuo; Zhiping Huang; David L Earnest; Alexander M Walker
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

Review 3.  Irritable bowel syndrome and chronic constipation: emerging drugs, devices, and surgical treatments.

Authors:  Lucinda A Harris; Stephanie Hansel; John DiBaise; Michael D Crowell
Journal:  Curr Gastroenterol Rep       Date:  2006-08

4.  Multiple somatic symptoms predict impaired health status in functional somatic syndromes.

Authors:  F H Creed; B Tomenson; C Chew-Graham; G J Macfarlane; I Davies; J Jackson; A Littlewood; J McBeth
Journal:  Int J Behav Med       Date:  2013-06

Review 5.  IBS--review and what's new.

Authors:  Amy Foxx-Orenstein
Journal:  MedGenMed       Date:  2006-07-26

6.  Irritable Bowel Syndrome: Bacterial Overgrowth--What's Known and What to Do.

Authors:  Mark Pimentel; Sheila Lezcano
Journal:  Curr Treat Options Gastroenterol       Date:  2007-08

7.  Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors?

Authors:  Savio C Reddymasu; Sandra Sostarich; Richard W McCallum
Journal:  BMC Gastroenterol       Date:  2010-02-22       Impact factor: 3.067

Review 8.  The burden of IBS: looking at metrics.

Authors:  Brennan M R Spiegel
Journal:  Curr Gastroenterol Rep       Date:  2009-08

Review 9.  Alosetron in irritable bowel syndrome: strategies for its use in a common gastrointestinal disorder.

Authors:  Anthony Lembo; H Christian Weber; Francis A Farraye
Journal:  Drugs       Date:  2003       Impact factor: 9.546

10.  Neural and psychological predictors of treatment response in irritable bowel syndrome patients with a 5-HT3 receptor antagonist: a pilot study.

Authors:  J M Jarcho; L Chang; M Berman; B Suyenobu; B D Naliboff; M D Lieberman; V Z Ameen; M A Mandelkern; E A Mayer
Journal:  Aliment Pharmacol Ther       Date:  2008-08-01       Impact factor: 8.171

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.